Multiple Approaches at Admission Based on Lung Ultrasound and Biomarkers Improves Risk Identification in COVID-19 Patients
Authors:
- Jorge Rubio-GraciaJRJorge Rubio-Gracia
- Marta Sánchez-MartelesMSMarta Sánchez-Marteles
- Vanesa Garcés-HornaVGVanesa Garcés-Horna
- Luis Martínez-LostaoLMLuis Martínez-Lostao
- Fernando Ruiz-LaiglesiaFRFernando Ruiz-Laiglesia
- Silvia Crespo-AznarezSCSilvia Crespo-Aznarez
- Natacha Peña-FresnedaNPNatacha Peña-Fresneda
- Borja Gracia-TelloBGBorja Gracia-Tello
- Alberto CebolladaACAlberto Cebollada
- Patricia Carrera-LasfuentesPCPatricia Carrera-Lasfuentes
- Juan Ignacio Pérez-CalvoJPJuan Ignacio Pérez-Calvo
- Ignacio Giménez-LópezIGIgnacio Giménez-López
Open Access
- 23 November 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5478
Abstract
Background: Risk stratification of COVID-19 patients is fundamental to improving prognosis and selecting the right treatment. We hypothesized that a combination of lung ultrasound (LUZ-score), biomarkers (sST2), and clinical models (PANDEMYC score) could be useful to improve risk stratification. Methods: This was a prospective cohort study designed to analyze the prognostic value of lung ultrasound, sST2, and PANDEMYC score in COVID-19 patients. The primary endpoint was in-hospital death and/or admission to the intensive care unit. The total length of hospital stay, increase of oxygen flow, or escalated medical treatment during the first 72 h were secondary endpoints. Results: a total of 144 patients were included; the mean age was 57.5 ± 12.78 years. The median PANDEMYC score was 243 (52), the median LUZ-score was 21 (10), and the median sST2 was 53.1 ng/mL (30.9). Soluble ST2 showed the best predictive capacity for the primary endpoint (AUC = 0.764 (0.658–0.871); p = 0.001), towards the PANDEMYC score (AUC = 0.762 (0.655–0.870); p = 0.001) and LUZ-score (AUC = 0.749 (0.596–0.901); p = 0.002). Taken together, these three tools significantly improved the risk capacity (AUC = 0.840 (0.727–0.953); p ≤ 0.001). Conclusions: The PANDEMYC score, lung ultrasound, and sST2 concentrations upon admission for COVID-19 are independent predictors of intra-hospital death and/or the need for admission to the ICU for mechanical ventilation. The combination of these predictive tools improves the predictive power compared to each one separately. The use of decision trees, based on multivariate models, could be useful in clinical practice.Keywords
This publication has 38 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Prognostic Biomarker Soluble ST2 Exhibits Diurnal Variation in Chronic Heart Failure PatientsESC Heart Failure, 2020
- A Preliminary Study on the Ultrasonic Manifestations of Peripulmonary Lesions of Non-Critical Novel Coronavirus Pneumonia (COVID-19)SSRN Electronic Journal, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Lung Ultrasound Integrated with Clinical Assessment for the Diagnosis of Acute Decompensated Heart Failure in the Emergency Department: A Randomized Controlled TrialEuropean Journal of Heart Failure, 2019
- Pulmonary Production of Soluble ST2 in Heart FailureCirculation: Heart Failure, 2018
- Soluble ST2 Testing: A Promising Biomarker in the Management of Heart FailureArquivos Brasileiros de Cardiologia, 2015
- Soluble ST2, High-Sensitivity Troponin T- and N-Terminal Pro-B-Type Natriuretic Peptide: Complementary Role for Risk Stratification in Acutely Decompensated Heart FailureEuropean Journal of Heart Failure, 2011
- Ensemble Methods in Data Mining: Improving Accuracy Through Combining PredictionsSynthesis Lectures on Data Mining and Knowledge Discovery, 2010
- Comparing the Areas Under Two Correlated ROC Curves: Parametric and Non‐Parametric ApproachesBiometrical Journal, 2006